CoreAge Rx vs Nucore Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Nucore Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Nucore Health a bad call — it's best for readers who want to compare injection and compounded oral routes and can confirm the actual prescription, recurring term and refund status. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Nucore Health |
|---|---|---|
| Brief Score | 94/100 (A) | 65/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Injection advertised from $179/month Compounded oral option from $209/month; final formulation, supplied quantity, term and total unconfirmed. No membership fee advertised; recurring programs still require seventy-two-hour cancellation notice. Full price detailsCompounded semaglutide offered; complete selected-plan quote unknown; injection advertised from $179/month and compounded oral option from $209/month; final formulation and price require review |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Injection advertised from $269/month Compounded treatment; final supplied quantity, recurring term and complete quote unconfirmed. Refund eligibility can end when pharmacy ordering or processing begins, before shipment. Full price detailsCompounded tirzepatide offered; complete selected-plan quote unknown; injection advertised from $269/month; supplied quantity, term and final price require review |
| Coverage | US only; restrictions by state, confirmed at intake | Availability varies; current medication-specific state list and assigned clinician/pharmacy eligibility require confirmation |
| Brand-name access | Not confirmed | Reviewed GLP-1 options are compounded; current branded fulfillment was not established. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Nucore Health: Injection starting advertisements: $179 semaglutide/$269 tirzepatide; compounded oral semaglutide $209. Final selected supply, price and recurring term unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.